Clathrin complexes in Arabidopsis consist of three heavy chains (CHC1, CHC2) and three light chains (CLC1, CLC2, CLC3). At3g51890 encodes CLC3, which localizes to the trans-Golgi network/early endosomes (TGN/EE) and plasma membrane (PM) . Key findings include:
Post-Golgi Trafficking: CLC3 interacts with adaptor protein complex 1 (AP-1) to regulate clathrin recruitment at TGN/EE. AP-1 mutants (e.g., ap1μ2) show 50–60% reduction in TGN/EE-associated clathrin levels .
Endocytosis Modulation: Loss of AP-1 reduces clathrin-mediated endocytosis (CME) of FM4-64 dye by 40–60% in root cells, demonstrating CLC3's role in vesicle internalization .
Compensatory Mechanisms: Downregulation of CLC3 increases CHC2 and CLC2 expression, suggesting functional redundancy among clathrin isoforms .
The antibody detects endogenous CLC3 in Arabidopsis extracts, with validation via:
Colocalization studies using GFP-tagged CLC3 and CHC2 in ap1μ2 mutants .
Quantitative immunofluorescence showing reduced TGN/EE clathrin signals in AP-1-deficient plants .
While the At3g51890 antibody is widely used, its validation aligns with broader challenges in antibody reliability:
Specificity: Cross-reactivity with CLC1/CLC2 is mitigated by antigen-affinity purification .
Reproducibility: Studies emphasize the need for multiple validation methods (e.g., GFP tagging, mutant analysis) to confirm antibody specificity .
Storage Stability: Glycerol-based formulation ensures long-term stability but requires strict adherence to -20°C/-80°C storage .
| Isoform | Gene ID | Localization | Functional Role |
|---|---|---|---|
| CLC1 | At2g20760 | PM, TGN/EE | Constitutive endocytosis |
| CLC2 | At2g40060 | TGN/EE, chloroplasts | Stress-induced vesiculation |
| CLC3 | At3g51890 | TGN/EE, PM | AP-1–dependent trafficking |
Here’s a structured collection of research-focused FAQs for At3g51890 antibody, synthesized from peer-reviewed studies and technical methodologies:
Signal amplification: Use tyramide-based systems for weak epitopes while maintaining spatial resolution .
Multiplex validation: Pair antibody staining with fluorescent protein-tagged At3g51890 transgenic lines for co-localization analysis .
Quantitative thresholds: Establish cutoff values for signal intensity using RNAi knockdown lines (e.g., ≤30% residual expression as baseline) .
Genetic: Compare phenotypes of CRISPR-Cas9 knockout lines with antibody-based protein depletion .
Biochemical: Co-immunoprecipitation followed by mass spectrometry to identify interaction partners .
Biophysical: Surface plasmon resonance (SPR) to quantify binding kinetics (KD ≤10 nM recommended for high-affinity interactions) .
Normalize signals to reference standards (e.g., recombinant At3g51890-His tagged protein) included in each experiment .
Implement multivariate ANOVA to account for:
Phage display mutagenesis: Identify critical residues using alanine-scanning libraries .
HDX-MS: Map solvent-accessible regions via hydrogen-deuterium exchange .
In silico docking: Predict binding interfaces using RosettaAntibody with experimental constraints .
Stress-specific controls:
NaCl (150 mM) for osmotic stress
Methyl viologen (10 μM) for oxidative stress
Temporal controls: Pre-stress vs. 6/12/24 hr post-treatment timepoints
Size-exclusion chromatography: Compare elution profiles with/without crosslinkers .
Blue native PAGE: Confirm co-migration with known complex subunits .
Single-particle tracking: Quantify dwell times on membrane microdomains .